ARSD 44:90:09:05
44 : 90 : 09 : 05 . Payment of fees associated with testing. The medical cannabis establishment submitting the cannabis or cannabis products for testing shall pay all fees associated with testing.
Source: 48 SDR 40, effective October 5, 2021; 49 SDR 9, effective August 8, 2022.
General Authority: SDCL 34-20G-72 (5)(d)(e) (l) .
Law Implemented: SDCL 34-20G-72 (5).
Prior versions effective: 2021-10-05.